Intrinsic Value of S&P & Nasdaq Contact Us

NLS Pharmaceutics AG NLSPW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CH • USD

SharesGrow Score
49/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — NLSPW

NLS Pharmaceutics AG (NLSPW) has a market capitalization of $7.43K and trades at $0.02. The 52-week range is 0.001-0.07.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-26.30.

The stock has a beta of 0.13, operates in the Healthcare sector.

Trading Data
Current Price$0.02
52-Week Range0.001-0.07
Volume14.34K
Avg Volume (30D)38.55K
Market Cap$7.43K
Beta (1Y)0.13
Company
IPO Date2021-01-29
Employees3
CEOAlexander Zwyer
CountryCH
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINCH0573155204
CUSIPH57830103
Income (Latest Year)
Gross Profit$-3.32K
EBITDA$-3.63M
Operating Income$-4.38M
Net Income$-1.98M
EPS$-26.30
EPS Diluted$-26.30
Shares Outstanding$75.3K
Balance Sheet (Latest Year)
Total Assets$2.23M
Current Assets$2.23M
Cash & ST Investments$1.67M
Total Liabilities$826.76K
Net Debt$-1.67M
Total Equity$1.41M
Valuation Ratios
P/E Ratio-0
P/B Ratio0.01
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message